Lexington, MA, United States of America

Michael Taylor

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ensemble Therapeutics Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Taylor. Retrieved from https://idiyas.com/inventor/michael-taylor-00z329ad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Michael Taylor

Introduction: Michael Taylor is an accomplished inventor based in Lexington, MA, with a notable patent to his name. His work primarily focuses on macrocyclic compounds that hold therapeutic potential in treating various medical conditions.

Latest Patents: Michael holds a patent for "Macrocyclic Compounds for Modulating IL-17." This invention involves unique macrocyclic compounds designed to modulate the activity of IL-17, a critical target in the treatment of inflammatory diseases and other disorders associated with IL-17. The potential implications of this invention could significantly impact therapeutic methods for tackling these medical issues.

Career Highlights: Michael is affiliated with Ensemble Therapeutics Corporation, a company recognized for its innovative approaches in pharmaceuticals and biotechnology. His role as an inventor enables him to contribute to advanced scientific research and development, pushing the boundaries of current medical therapies.

Collaborations: Throughout his career, Michael has collaborated with notable professionals, including Nicholas K. Terrett and William H. Connors. These partnerships reflect his commitment to collective innovation and the sharing of ideas among experts in the field.

Conclusion: Michael Taylor's contributions in the realm of macrocyclic compounds highlight the intersection of innovative science and therapeutic development. His patent, along with his work at Ensemble Therapeutics Corporation, serves as a testament to his dedication to advancing healthcare solutions through inventive methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…